Article

Telemedicine forum helps ophthalmologists stay connected amid COVID-19

Telemedicine forum

In a moment of national peril, when the physician-patient relationship has been severed by COVID-19 pandemic precautions, telemedicine has never mattered more.

In a moment of national peril, when the physician-patient relationship has been severed by COVID-19 pandemic precautions, telemedicine has never mattered more.

Ophthalmologists are joining together and generating a communication network/feedback loop called “Eye Care Pandemic Response/Tele-VisionMD” to share best practices in telemedicine adaptation.

The formation of this network has been “motivated by love and concern for our patients, our support teams, our colleagues and our country,” according to its founders.

Among the founding co-chairs* are Eduardo Alfonso, MD, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami; Julia Haller, MD, Wills Eye Hospital, Philadelphia; and Peter McDonnell, MD, director of the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore.

Co-founding directors include Dr. Alfonso; Michael Boland, MD, associate professor of ophthalmology, Wilmer Eye Institute; Warren (Chip) Fagadau, MD, clinical assistant professor at the University of Texas Southwestern Medical School, Dallas; Ranya Habash, MD, assistant professor of clinical ophthalmology, Bascom Palmer Eye Institute; Dr. Haller; Dr. McDonnell; and Jonathan Myers, MD, chief of the Glaucoma Service, Wills Eye Hospital.

The network will serve “to access the combined resources of our cherished academic institutions, and to tap the latent collective creativity and clinical insights of practitioners in the field,” according to the group.

As an initial step in this direction, an online forum has been created for eyecare providers to both ask questions and share personal experiences with regard to COVID-19 and telemedicine.

To join the conversation, go to https://groups.google.com/forum/#!forum/eye-care-pandemic-response and request to join the group. If “pending approval” appears on the screen, access should be approved within 24 hours.

In addition, plans are in development for a more robust online platform (Tele-VisionMD.org) to facilitate interaction regarding telemedicine in eye care. This platform will remain non-profit and non-proprietary, freely available in order to maximize collaboration.

*Editor’s Note: It should be noted that institutions have not been identified as endorsers or sponsors. Rather, ophthalmologists are joining as individuals to bring collective intelligence to fellow colleagues.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.